Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.
Submissions from 2026
9-15-2026 Demographics and clinical implications of a global bibliographic profile for the hypertrophic cardiomyopathy literature over 66 years (1960-2025), Ahmed Sayed, Rochester Regional Health, Ethan J. Rowin, Martin S. Maron, et al.
9-1-2026 Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis, Hossam Elbenawi, Ibrahim Hassan, Mahmoud Shaaban Abdelgalil, et al.
9-1-2026 Hydrocortisone Use for Septic Shock in Patients With CKD, Parth Dhamelia, Hashane Abeyagunawardene, Rajshekhar A. Kore, et al.
8-1-2026 Acute Interstitial Nephritis after Single Dose of Ketorolac, Ishan Jani, Rochester Regional Health; Arjun Sekar, Rochester Regional Health; and Sergey Brodsky
8-1-2026 Disparities in Palliative Care Utilization in Metastatic Triple-negative Breast Cancer: A National Cancer Database Study, Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Akshjot Puri, et al.
8-1-2026 Real-world Clinical and Diagnostic Features of Patients With Isolated Anti-SSB Antibodies Compared With Those With Combined Anti-SSA and Anti-SSB Antibodies, Massiel Jimenez, Asim Khanfar, Rochester Regional Health, Pratibha Chaudhary, et al.
8-1-2026 Workforce Perception and Awareness of Sustainability in Gastrointestinal Endoscopy: A Systematic Review of Green Endoscopy, Hareesha Rishab Bharadwaj, Syed Hasham Ali, Thai Hau Koo, et al.
7-14-2026 Clinicopathologic features, treatment patterns and survival outcomes of acinic cell carcinoma of the breast: a national cancer database analysis., Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Akshjot Puri, et al.
7-6-2026 Disparities in palliative care settings among patients with renal cell carcinoma in the United States: a nationwide population-based study, Cher Ying Foo, Rochester Regional Health; Ojasav Sehrawat, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health
7-1-2026 Clinicopathologic features, treatment patterns, and survival outcomes of glycogen-rich clear cell carcinoma of the breast: A National Cancer Database Analysis, Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Waqar Haque, et al.
7-1-2026 Comparative outcomes and characteristics of biliary, alcoholic and drug-induced pancreatitis based on the National Inpatient Sample (2016-2021), Omar Alkasabrah, Sameeha Ibrahim, Abdullah Hafeez, et al.
7-1-2026 Drug-induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge, Kavya Balusu, Rochester Regional Health, Syed Usman Mohsin Ehsanullah, Rochester Regional Health, Jennifer Olejniczak, Rochester Regional Health, et al.
7-1-2026 Gastrointestinal and Hepatobiliary Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes, Chengu Niu, Rochester Regional Health, Kefang Sun, Rochester Regional Health, Jing Zhang, et al.
7-1-2026 Impact of Pulmonary Rehabilitation on Physical Functioning, Exercise Capacity and Sleep Disturbances in Post-tuberculosis Cases: A systematic Review, C K. Safareena, Shahzaad Hussain, Shweta Jha, et al.
7-1-2026 Isolated Extreme Thrombocytosis as the Presenting Feature of Chronic Myeloid Leukemia-An Unusual Phenotype Treated With Plateletpheresis, Kavya Balusu, Rochester Regional Health; Abdullah A. Orakzai, Rochester Regional Health; and Farhan S. Imran, Rochester Regional Health
7-1-2026 Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia, Jiun-Lu Lin, Christine Hsu, Shao-Wei Lo, et al.
7-1-2026 Place of death patterns among patients with renal cell carcinoma in the United States: A 24-year nationwide analysis, Cher Ying Foo, Rochester Regional Health; Ojasav Sehrawat, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health
7-1-2026 Real-world treatment patterns and survival outcomes in acinic cell carcinoma of the breast: A National Cancer Database study, Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Waqar Haque, et al.
7-1-2026 Thrombotic thrombocytopenic purpura associated with acalculous cholecystitis masquerading as immune thrombocytopenia, Kavya Balusu, Rochester Regional Health, Purva Shah, Rochester Regional Health, Nagesh Jadhav, Rochester Regional Health, et al.
6-27-2026 Sodium-Glucose Cotransporter-2 Inhibitors Are Associated with Improved Survival in Patients with Cirrhosis, Hatem Ahmed, Sameh Gomaa, Mohammad Alazzeh, et al.
6-22-2026 TCF7L2 promotes abdominal aortic aneurysm through smooth muscle cell-mediated extracellular matrix remodeling, Yongjie Deng, Yaozhong Liu, Yang Zhao, et al.
6-10-2026 Rochester General Hospital Internal Medicine Residency Program Research Showcase: 2026-06-10, Muhammad Hamza Asif, Rochester Regional Health; Muhammad Muaz Mushtaq, Rochester Regional Health; Ahmed Sayed, Rochester Regional Health; and Kefang Sun, Rochester Regional Health
6-3-2026 Clinical Reasoning and Graduate Medical Education in the Era of AI, Ali S. Mohamed, Rochester Regional Health; Nauman Naeem, Rochester Regional Health; and Mouna Reghis, Rochester Regional Health
6-1-2026 Association between chemotherapy-induced neuropathy and gabapentin exposure among adults receiving chemotherapy: A National Inpatient Sample study (2017-2021), Mahima Shenoi, Rochester Regional Health, Purva Shah, Rochester Regional Health, Candrika D. Khairani, Rochester Regional Health, et al.
6-1-2026 Association between gabapentinoid exposure and chemotherapy-associated peripheral neuropathy among adults starting new neurotoxic chemotherapy in a multi-hospital health system, Candrika D. Khairani, Rochester Regional Health, Mahima Shenoi, Rochester Regional Health, Purva Shah, Rochester Regional Health, et al.